ArticleCells2023

Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α.

Sumita Raha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.